Optiver Holding
TNYA icon

Optiver Holding’s Tenaya Therapeutics TNYA Stock Holding History

Optiver Holding’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65 Buy
94
+40
+74% +$30 ﹤0.01% 2254
2025
Q4 		$38 Hold
54
– – ﹤0.01% 2401
2025
Q3 		$87 Buy
+54
New +$54 ﹤0.01% 2601

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optiver Holding's TNYA Position: Q1 2026 in Review

Optiver Holding increased its Tenaya Therapeutics (TNYA) stake by 74% in Q1 2026, buying an estimated $30 and bringing the position to 94 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Optiver Holding first reported a position in TNYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $87 in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Optiver Holding held 94 shares of Tenaya Therapeutics worth $65 as of Q1 2026.
  • Optiver Holding bought 40 Tenaya Therapeutics shares in Q1 2026, an estimated $30.
  • Tenaya Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2254 holding.
  • Optiver Holding first reported a position in Tenaya Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Tenaya Therapeutics position peaked at $87 in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.